Congenital heart disease


Congenital heart disease (CHD) occurs in approximately 4 to 10 cases per 1000 live births. These numbers do not include bicuspid aortic valves, which would double or triple the incidence. Overall, CHD accounts for approximately a third of all congenital defects. Moreover, in developed countries, CHD has become the principal cause of heart failure in children, with 10% to 15% having other associated congenital anomalies of the skeletal, genitourinary, or gastrointestinal system. The incidence of CHD in children has remained constant over the last few decades. However, as therapeutic options have increased life expectancy, the overall prevalence of adults with CHD has steadily increased. It is estimated that in the United States, more adults than children are currently living with CHD. This trend is reflected in an ever-rising number of patients presenting for cardiac surgery, including primary repair, revision of a prior operation, conversion to a more modern operation, or treatment of long-term sequelae, or undergoing noncardiac surgery that is unrelated to their congenital cardiac defect. Fortunately, fewer than a dozen lesions, most of them acyanotic, comprise almost 90% of CHD encountered in adulthood ( Table 7.1 ).

TABLE 7.1
Classification and Incidence of Congenital Heart Disease
Disease Incidence (%)
Acyanotic Defects
  • Shunting lesions

  • Ventricular septal defect

37
  • Atrial septal defect

9
  • Patent ductus arteriosus

8
  • Atrioventricular septal defect

4
  • Stenotic lesions

  • Pulmonary stenosis

8
  • Aortic stenosis

4
  • Coarctation of the aorta

4
Cyanotic Defects
Tetralogy of Fallot 4
Transposition of the great vessels 3
Hypoplastic left heart 3
Hypoplastic right heart 2

It is common for physicians to diagnose CHD in utero during the routine fetal anatomy ultrasonography screen. Diagnosing CHD post utero has evolved from fairly crude methods (auscultation, chest x-rays, and phenotypical appearance) to highly sophisticated imaging modalities such as echocardiography, cardiac catheterization, and magnetic resonance imaging (MRI). These techniques also make it possible to (1) accurately visualize minute details of cardiac function, blood flow, and driving pressures and (2) predict (to a certain extent) the perioperative course and long-term prognosis. Patients with milder forms of CHD may go undiagnosed in the perinatal period, and instead be diagnosed only later in life. Diagnosis may occur when an incidental heart murmur is detected on physical examination, or during the workup of conditions such as failure to thrive, feeding intolerance, or new-onset arrhythmias. Any provider caring for such patients needs to be aware of the many problems that can occur with CHD ( Table 7.2 ).

TABLE 7.2
Common Problems Associated With Congenital Heart Disease
Cardiac
Dysrhythmias
Conduction defects
Pulmonary hypertension (Eisenmenger syndrome)
Endocarditis
Heart failure
Pulmonary
Cyanosis
Altered response to hypoxia or hypercarbia
Decreased lung compliance
Chronic lung disease
Hemoptysis
Airway compression
Vascular
Prior cannulation sites complicating the ability to gain vascular access
Renal
Chronic renal insufficiency
Renal failure
Hepatobiliary
Cholelithiasis
Hepatic congestion
Protein-losing enteropathy
Central Nervous System
Brain abscesses
Seizures
Strokes
Paradoxical emboli
Developmental status
Peripheral Nervous System
Phrenic nerve paralysis
Recurrent nerve paralysis
Hematologic
Erythrocytosis (hyperviscosity syndrome)
Abnormal coagulation studies
Thromboembolism
Coagulopathy
Musculoskeletal
Higher incidence of scoliosis
Miscellaneous
Decreased exercise tolerance
Failure to thrive and feeding difficulties in children

Congenital heart lesions

Acyanotic congenital heart disease

Shunting lesions

Acyanotic shunting lesions are principally characterized by blood flow that shunts from left to right inside the heart or the proximal great vessels ( Table 7.3 ). This shunting leads to increased pulmonary blood flow that then increases pulmonary vascular resistance, leading to intimal hyperplasia and vascular remodeling. All these effects cumulate in pulmonary hypertension, right ventricular hypertrophy, and, eventually, congestive heart failure. In general, the younger the patient at the time of surgical repair, the greater the likelihood that pulmonary vascular resistance will normalize. Survival in such patients is usually excellent, especially if shunting is restrictive. However, if the defect is not repaired until the patient is in his or her late teens or adulthood, and shunting involves more than one-third of cardiac output, long-term sequelae are highly likely, including the development of pulmonary hypertension, ventricular remodeling, and congestive heart failure.

TABLE 7.3
Congenital Heart Defects Resulting in Left-to-Right Shunting
  • Atrial septal defect

  • Ostium primum defect

  • Ostium secundum defect

  • Sinus venosus defect

  • Unroofed coronary sinus

  • Ventricular septal defect

  • Subarterial ventricular septal defect

  • Perimembranous ventricular septal defect

  • Inlet ventricular septal defect

  • Muscular ventricular septal defect

  • Patent ductus arteriosus

  • Aortopulmonary fenestration

Atrial septal defect

Atrial septal defects (ASDs) account for the majority of congenital heart lesions detected in adults. Small ASDs do not usually cause symptoms for decades and therefore frequently remain undiagnosed until adulthood.

Depending on the embryologic origin and location of the defect in the interatrial septum and the specific point of shunting, one can differentiate four different types of ASDs ( Fig. 7.1 ). An ostium primum defect occurs when the ostium primum fails to fuse with the endocardial cushions. The result is a defect in the interatrial septum that is located caudally just above the atrioventricular valves. The ostium secundum defect, the most common type of ASD (75% of all ASDs), is located in the middle of the interatrial septum in the same location as the foramen ovale and varies from a single opening to a fenestrated septum. The two remaining ASDs, the sinus venosus defect (located at either the superior vena cava or the inferior vena cava junction) and the unroofed coronary sinus (opening of the coronary sinus into the left atrium via its crossing behind the heart), occur with the least frequency. Importantly, ASDs do not always present in isolation but can be part of complex syndromes, each associated with other specific lesions. Specifically, ostium primum defects are associated with a cleft mitral valve and/or mitral regurgitation, ostium secundum defects are associated with mitral valve prolapse and/or regurgitation, sinus venous defects are associated with anomalous right pulmonary venous return, and an unroofed coronary sinus is associated with a persistent left superior vena cava.

Fig. 7.1, Atrial septum defect. (A) Secundum atrial septal defect, in which blood flows left to right across the atrial septum along a pressure gradient. (B) Schematic drawing of the locations of atrial septal defects: (1) septum primum defect, (2) septum secundum defect, (3) sinus venosus defects, (4) unroofed coronary sinus. Ao, Aorta; IVC, inferior vena cava; LA, left atrium; LV, left ventricle; PA, pulmonary artery; PV, pulmonary vein; RV, right ventricle; SVC, superior vena cava.

Regardless of the type of ASD, the resulting physiologic changes depend on the degree of net blood shunting from the left to the right atrium. The degree of shunting, in turn, depends not only on the pressure difference between the two chambers but also on the size of the lesion and the relative compliance of the ventricles. The resulting, mostly left-to-right, shunt increases pulmonary blood flow and causes volume overloading of the lung, right ventricle, and right atrium. Smaller defects result in minor shunts that are mostly without hemodynamic consequences and can be tolerated well into adulthood. Larger ASDs that allow more than a 50% increase in pulmonary blood flow can have severe consequences such as pulmonary hypertension, ventricular remodeling, and dysrhythmias.

Similar to many other congenital heart lesions, diagnosis in asymptomatic patients is often initiated after auscultation of a heart murmur. An electrocardiogram (ECG) might reveal signs of right axis deviation and an incomplete right bundle branch block (RBBB) from right ventricular strain. A chest x-ray may show enlarged pulmonary arteries, prominent lung vasculature, and cardiomegaly. The diagnosis is confirmed by using echocardiography to determine the location of the ASD, the degree of shunting, the direction of blood flow, and associated cardiac anomalies.

Signs and symptoms.

Patients can present with increasing dyspnea on exertion, decreased exercise tolerance, fatigue, heart failure, palpitations, or embolic stroke. However, many patients with ASDs will remain asymptomatic for years. Smaller defects with a ratio of pulmonary to systemic blood flow (Qp:Qs ratio) of less than 1.5:1 usually remain asymptomatic and do not require further intervention. Shunt lesions with a Qp:Qs ratio greater than 1.5:1 should be considered for closure to prevent long-term sequelae. Depending on the location and size of the ASD, the lesion can be closed percutaneously using a septal occlusion device in the catheterization suite or surgically with a primary or patch closure either via sternotomy or minimally invasive thoracotomy.

Management of anesthesia.

For general management strategies, including anesthetic management, see “Balancing Pulmonary and Vascular Resistance (Qp:Qs)” later in the chapter. Management of patients undergoing ASD closure depends largely on the chosen intervention. A percutaneous ASD closure can be conducted with standard American Society of Anesthesiology (ASA) monitoring and the patient under general anesthesia or deep sedation, whereas a surgical ASD repair requires all the routine monitors, access for cardiopulmonary bypass, and the capacity to treat/manage potential postoperative heart block.

Ventricular septal defect

When excluding bicuspid aortic valves, ventricular septal defects (VSDs) are the most prevalent form of CHD in children, comprising 30% of cases. Because of the high spontaneous closure rate, however, especially for muscular septal defects, VSDs in adults are rare. The classification of VSDs can be confusing because each of the four different lesions has multiple names according to its location in the interventricular septum ( Fig. 7.2 ). A VSD type I, also called subarterial, supracristal, outlet, subpulmonic, or infundibular VSD, is located high in the interventricular septum just below the pulmonic valve and above the crista terminalis. The most common VSD (more than two-thirds of all VSDs) is the type II VSD, also called the perimembranous or infracristal VSD, which is located lower in the septum just below the crista terminalis. A type III VSD, also called inlet or canal type VSD, is located just below the mitral and tricuspid valve. The last type of VSD, type IV or muscular VSD, is located deep in the muscular portion of the ventricular septum and can range from a single perforation to multiple holes of different sizes. Similar to ASDs, certain types of VSDs are associated with different lesions. Type I VSDs are associated with aortic insufficiency caused by prolapse of the aortic valve cusp. Type II VSDs are associated with tricuspid valve aneurysms or insufficiency caused by entrapment of the valve leaflets. Type III VSDs are associated with a cleft mitral valve or tricuspid valve and are part of the complete atrioventricular canal defect. Lastly, type IV VSDs can be associated with a multitude of different lesions but have the highest probability of closing spontaneously with time.

Fig. 7.2, Ventricular septal defect. (A) Schematic depiction of a ventricular septal defect resulting in a left-to-right shunting lesion. (B) Locations of the different types of ventricular septal defects: (1) outlet, (2) perimembranous, (3) inlet, (4) muscular. Ao, Aorta; IVC, inferior vena cava; LA, left atrium; LV, left ventricle; PA, pulmonary artery; PV, pulmonary vein; RV, right ventricle; SVC, superior vena cava.

Signs and symptoms.

The severity of signs and symptoms depends on the size of the defect, the pressure difference between the ventricles, and the ratio of pulmonary to systemic vascular resistance. Small defects with a Qp:Qs ratio of 1.4:1 or less usually remain asymptomatic and do not result in major sequelae (e.g., pulmonary hypertension or heart failure). These defects are usually referred to as restrictive VSDs, as the amount of shunting is restricted by the size of the defect. Moderately restrictive VSDs with a Qp:Qs ratio of 1.4:1 to 2.2:1 or nonrestrictive VSDs with a Qp:Qs ratio greater than 2.2:1 can result in an equalization of left and right ventricular systolic pressures that causes both volume and pressure overload of the pulmonary circulation. Over time, the pulmonary vasculature starts to remodel, resulting in increased pulmonary vascular resistance and pulmonary hypertension. Eventually a decrease in the Qp:Qs ratio results, leading to shunt reversal (Eisenmenger syndrome). Consequently, patients become progressively hypoxic as blood shunts right to left across the VSD and bypasses the lungs. Such patients are no longer candidates for VSD closure, as right heart failure would inevitably ensue. Over time, even in the absence of advanced disease and Eisenmenger syndrome, patients with moderate-restrictive or unrestrictive VSDs develop left ventricular failure and pulmonary hypertension, putting them at increased perioperative risk. Therefore it is important to diagnose patients early and perform a VSD closure before pulmonary vascular resistance increases to such high levels that closure is no longer possible.

With increasing size of the defect, the ECG can demonstrate signs of left atrial and left ventricular hypertrophy, as well as right ventricular strain. Similarly, chest x-rays will show an enlarged cardiac silhouette. Echocardiography with color Doppler is most commonly used to evaluate the presence, directionality, and severity of a VSD. Other more invasive techniques include cardiac catheterization and angiography to measure the amount of intracardiac shunting, intravascular and intracavitary pressures, and pulmonary and systemic vascular resistance.

Management of anesthesia.

The most conservative summary would probably be to treat a patient with a VSD of unknown severity like a patient with congestive heart failure and pulmonary hypertension. For general management strategies and anesthetic management, refer to “Balancing Pulmonary and Vascular Resistance (Qp:Qs)” later in the chapter.

Small VSDs can occasionally be closed percutaneously in older children and adults, otherwise surgical closure is performed. Children who undergo surgical VSD closure generally tolerate it very well.

Patent ductus arteriosus (PDA)

During fetal development, the ductus arteriosus provides vascular communication between the left pulmonary artery and the descending aorta just distal to the left subclavian artery. In utero, it allows oxygenated placental blood returning to the fetus to flow from the systemic venous circulation to the systemic arterial circulation; therefore the blood does not have to traverse the pulmonary vascular bed of the nonventilated lungs (right-to-left shunt). Within the first 24 hours after delivery, the ductus arteriosus begins to close and is completely sealed off within the first month of life. However, in some patients (especially in preterm babies), the ductus arteriosus does not close normally and instead remains patent, allowing blood to flow between the pulmonary arterial and systemic arterial vasculature ( Fig. 7.3 ). Over time, as pulmonary vascular resistance decreases, the flow of blood across the PDA occurs predominantly from the high-pressure aorta to the low-pressure pulmonary artery, resulting in a left-to-right shunt. The amount of blood shunting left to right depends on the resistance across the PDA (dependent on the diameter and length), the pressure difference between the aorta and the pulmonary artery, and both the pulmonary and systemic vascular resistance.

Fig. 7.3, Patent ductus arteriosus (PDA). Schematic depiction of a PDA connecting the distal aortic arch to the pulmonary artery (PA). This connection results in a left-to-right shunt, with blood flowing from the aorta (Ao) to the PA. IVC, Inferior vena cava; LA, left atrium; LV, left ventricle; PV, pulmonary vein; RA, right atrium; RV, right ventricle; SVC, superior vena cava.

Signs and symptoms.

Most patients with a PDA have only a mild or moderate left-to-right shunt, but symptoms of pulmonary overcirculation can develop over time. When the left-to-right shunt is substantial, patients can develop pulmonary hypertension that leads to heart failure, failure to thrive, aneurysmal dilatation of the ductus, and, in longstanding disease, Eisenmenger syndrome. Diagnosis and quantification can be established with echocardiography.

Management of anesthesia.

Most patients in whom the ductus fails to close spontaneously will require closure during the neonatal period, especially those born before 28 weeks of gestation. Many can be closed medically with indomethacin, which decreases the production of prostaglandins that keep the ductus open. However, side effects of the drug may preclude its use in some patients. In such cases, the ductus is closed with either a device or surgical ligation. Minimally invasive device closure is performed by interventional cardiology in the catheterization suite and usually requires only percutaneous arterial and venous access. When device closure is not feasible, surgical ligation is carried out via a left thoracotomy without cardiopulmonary bypass. When severe pulmonary hypertension is present, ductal closure may precipitate acute right heart failure, contraindicating closure.

For general management strategies and anesthetic management, see “Balancing Pulmonary and Vascular Resistance (Qp:Qs)” later in the chapter. During surgical ligation of the ductus arteriosus, single lung ventilation is rarely required; rather the surgeon gently retracts the lung out of the field. This action can lead to a temporary drop in oxygen saturation, given the high incidence of lung disease with poor lung compliance in premature infants. Often, the decrease in oxygen saturation may be minimized with ventilator adjustments. Ligation of the ductus results in an immediate increase in diastolic blood pressure. Adverse events include hoarseness (due to recurrent laryngeal nerve injury), hemidiaphragm paralysis (due to phrenic nerve injury), chylothorax (due to thoracic duct injury), and reopening of the ductus.

Obstructive lesions

Obstructive lesions are characterized by an increased resistance to blood flow around the level of the cardiac valves or the outflow tracts. In this section we will discuss the major left-sided obstructive lesion of the heart (aortic stenosis), its counterpart on the right side of the heart (pulmonic stenosis), and coarctation of the aorta (preductal and postductal). Increased pressure is required to overcome the stenosis, which leads to either left-sided or right-sided concentric hypertrophy and ultimately heart failure.

Aortic stenosis.

Stenosis of the left ventricular outflow tract can be due to subvalvular, valvular, or supravalvular aortic stenosis (AS). Valvular AS is frequently the result of a bicuspid aortic valve, which is present in approximately 2% of all newborns in the United States.

Patients with bicuspid aortic valves are generally not born with a stenosed valve. Rather, because the aortic valve has two (instead of the normal three) cusps, blood flow is more turbulent, leading to endothelial disruption and local inflammation that causes a predisposition for calcification. These factors all cumulate in premature AS. Severity is commonly determined by the pressure gradient across the aortic valve. A mean gradient less than 20 mm Hg is considered mild, whereas a mean gradient greater than 40 mm Hg is considered severe.

Signs and symptoms.

Most patients with bicuspid aortic valves remain asymptomatic until adulthood. Infants with severe AS suffer from feeding difficulties, poor growth, and heart failure. Supravalvular AS is much less common and is usually associated with Williams syndrome. During anesthesia, patients with supravalvular AS have a high risk of sudden death, typically from myocardial ischemia. The same is true for patients with subvalvular AS, which can be due to either a fixed stenosis (membrane, fibromuscular ridge, etc.) or dynamic left ventricular outflow tract obstruction.

The classic symptoms of patients with AS are syncope, angina, and dyspnea. In such patients, the left ventricle must generate higher than normal pressures to overcome the stenotic lesion, which is not reflected by a normal systemic blood pressure measured poststenosis. The logical consequence is concentric hypertrophy of the left ventricle, which, over time, increases oxygen requirements and decreases myocardial compliance. Consequently, left ventricle filling pressure increases and coronary perfusion pressure to the left ventricular myocardium decreases, leading to angina. Because of the high blood flow velocity and turbulent flow poststenosis, the aortic root and ascending aorta can respond with poststenotic dilation, necessitating the repair of not only the valve but also the root and perhaps the ascending aorta.

The ECG can demonstrate left ventricular hypertrophy with strain—especially during exercise. Chest x-rays show an enlarged left ventricular silhouette and potentially a prominent ascending aorta. Diagnosis is confirmed with echocardiography to evaluate the exact location of the stenosis, its severity, associated lesions or changes, and ventricular function. Rarely is cardiac catheterization and angiography needed to assess severity and associated lesions.

Management of anesthesia.

See Chapter 6 and its section about aortic stenosis for details on anesthetic management.

Pulmonic stenosis.

Many of the concepts for AS can be translated to pulmonary stenosis, with the main difference being that the right ventricle is much more sensitive to increases in afterload. Pulmonary stenosis is mainly valvular in origin rather than supravalvular or subvalvular. Associated lesions, especially of supravalvular pulmonic stenosis, include ASDs, VSDs, a PDA, and tetralogy of Fallot. Supravalvular pulmonic stenosis can also occur in patients with Williams syndrome (distinctive phenotype, developmental delay, hypercalcemia, and stenosis of the aorta and/or pulmonary artery). Subvalvular pulmonic stenosis is typically associated with a VSD, whereas valvular pulmonic stenosis tends to occur in isolation or sometimes in combination with a VSD. Interestingly, peak pressure gradients are frequently used for the classification of pulmonic stenosis (as opposed to mean gradients), with less than 36 mm Hg being mild and more than 64 mm Hg being considered severe.

Signs and symptoms.

Symptoms depend on the severity and associated defects (e.g., cyanosis that is present in severe cases associated with a VSD). In general, patients will present with signs of right heart failure, including dyspnea, jugular venous distension, hepatomegaly, peripheral edema, and ascites. The ECG may reveal signs of right ventricular hypertrophy and strain. Echocardiography or MRI can be used to confirm and classify the type and severity of the lesion.

Management of anesthesia.

Pulmonary stenosis can be treated with open surgery that requires cardiopulmonary bypass, or it can be treated percutaneously via balloon valvuloplasty. For any patient with pulmonary stenosis undergoing surgery, the anesthetic goals are to avoid increases in right ventricular oxygen demand. See Chapter 6 and its section about pulmonic stenosis for details on anesthetic management.

Coarctation of the aorta.

Coarctation of the aorta consists of aortic narrowing and is often classified by its proximity to the ductus arteriosus—preductal, juxtaductal, or postductal. Depending on its location, symptoms and age at diagnosis tend to vary. The most common form, postductal coarctation, lies beyond the ductus arteriosus and is sometimes diagnosed outside the neonatal period. A preductal coarctation is located proximal to the ductus and usually manifests in the neonatal period.

Signs and symptoms.

All forms of aortic coarctation share adverse outcomes common to systolic hypertension, such as congestive heart failure, aortic dissection, premature coronary artery disease, and intracerebral hemorrhage caused by aneurysm rupture.

Signs and symptoms depend not only on the severity of the coarctation but also on its location (preductal vs. postductal). In general, presenting symptoms include headache, dizziness, palpitations, and epistaxis. Individuals with postductal aortic coarctation may remain asymptomatic as infants and come to medical attention later for the workup of headaches or hypertension. A blood pressure difference between the upper (hypertensive) and lower (normotensive or hypotensive) extremities or weak and delayed femoral pulses are present. In severe cases of diminished lower extremity blood flow, lower extremity claudication can occur. Infants with preductal aortic coarctation, on the other hand, tend to become symptomatic earlier in life, as they have selective cyanosis of the lower extremity with a pink face and upper extremities. If the coarctation is not repaired at that time, the difference in blood pressure between the upper and lower extremities tends to decrease as those children develop extensive collateral blood flow involving the internal thoracic, intercostal, and subclavian arteries.

The ECG shows the classic signs of left ventricular hypertrophy, as does the chest x-ray. Chest x-ray can also reveal notching in the posterior parts of the ribs as a sign of increased collateral blood flow in the intercostal arteries. The definite diagnosis can be made with echocardiography, computed tomography (CT), or MRI, which can classify the location and severity of the stenosis. The latter two techniques can be used to quantify the degree of collateral flow.

Management of anesthesia.

Coarctation ideally should be repaired in infancy or early childhood before patients develop systemic hypertension. Once hypertension develops, the risk is high that it will persist despite an adequate repair. Although coarctation can be repaired percutaneously by a balloon dilatation and stent placement, open surgical resection with an end-to-end anastomosis remains the treatment of choice in infants.

Surgical repair generally does not involve cardiopulmonary bypass, but it does require a high (proximal) aortic cross clamp. Placement of the cross clamp necessitates the management of two circulations (proximal and distal to the clamp) with very different blood pressures. Importantly, the tighter the aortic stenosis, the fewer hemodynamic perturbations arise during placement of the cross clamp. The proximal circulation (heart, head, and upper extremity) is exposed to a relatively high pressure that has the potential to cause heart failure and cerebral hemorrhage. The distal circulation (especially the gut, kidneys, spinal cord, and lower extremities) is faced with the opposite problem, profound hypotension and hypoperfusion (depending on the amount of collateral blood flow), potentially leading to gut ischemia, renal failure, or, in rare cases, paraplegia. Blood pressure should be monitored continuously above the cross clamp, which leaves only the right arm as a reliable source (blood supply to the left arm can be compromised during the repair). Blood pressure should also be monitored below the level of the cross clamp to ensure adequate perfusion via the collaterals during cross clamping and to verify the absence of a pressure gradient after the repair. Alternatively, partial circulatory bypass might be used to ensure lower body perfusion during more complex repairs.

Patients are at risk for paradoxic hypertension, which is thought to be triggered by a baroreceptor reflex, activation of the renin-angiotensin-aldosterone system, or excessive release of catecholamines. Initial treatment includes the infusion of arteriolar vasodilators. The most common nerve injury is damage to the left laryngeal nerve that leads to stridor or hoarseness. Phrenic nerve damage is less common but could result in the need for prolonged respiratory support.

Ebstein anomaly.

Ebstein anomaly is rare (<1%) and produces an acyanotic lesion if it occurs as an isolated entity. However, it can be associated with other shunting lesions that in combination with right ventricular outflow tract obstruction render those patients cyanotic. Patients with Ebstein anomaly have an atrialized right ventricle, with a malformed and caudally displaced tricuspid valve. Frequently, the anterior cusp is sail-like in structure with multiple fenestrations, resulting in tricuspid insufficiency and, in rare instances, stenosis. With the tricuspid valve displaced downward, the effective right ventricle is relatively small and inefficient.

Signs and symptoms.

Severity of symptoms is proportional to the degree of tricuspid valve displacement and function. Sequelae can range from congestive heart failure, syncope, and dysrhythmias to an incidental finding with no symptoms at all. If patients have an associated shunting lesion, they are at risk for paradoxic emboli and hypoxia. More severe cases are usually found in neonates, who will require surgical intervention to survive and may not be candidates for a two-ventricle repair.

The ECG can show right ventricular hypertrophy and conduction abnormalities, such as a RBBB or first-degree atrioventricular block. Some may also have signs of paroxysmal supraventricular or ventricular tachyarrhythmias, or preexcitation syndromes. Chest x-rays can show right ventricular and atrial enlargement, which might compress lung tissue. The actual right ventricular cavity, however, remains small and inefficient, as revealed by additional findings of right ventricular failure, such as a dilated azygos vein and dilation of the right atrium. In severe disease, the shape of the heart approximates a sphere. Echocardiography is used to visualize the extent of atrial dilation, tricuspid valve anatomy, and tricuspid regurgitation, as well as associated shunting lesions and their severity.

Management of anesthesia.

Symptomatic treatment includes pharmacologic therapy for heart failure and arrhythmias, as well as catheter-based ablation of accessory pathways to treat excitation syndromes. Surgical repair can be quite complex. If primary repair of the lesion is not feasible, a staged procedure along the single ventricle palliation pathway might be required.

Management of anesthesia depends on the severity of right ventricular dysfunction, the functional status of the tricuspid valve, the presence of arrhythmias, and associated shunting lesions. General management strategies and anesthetic management are discussed later under “Important Management Strategies for Adults with Congenital Heart Disease.”

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here